HEALTHTHE GUARDIAN WORLD
Lupus patients in England in remission after pioneering NHS trial of GM therapy
Five lupus patients in England are in remission after participating in an NHS trial of CAR T-cell therapy, which genetically modifies their T-cells to target and destroy the disease. Doctors describe this as a medical breakthrough that could offer a cure for chronic autoimmune diseases.
Mentioned
Related Signal
Adjacent reporting
- A revolutionary cancer treatment could transform autoimmune disease
- 'I've never been this good' – revolutionary immune reset puts lupus in remission
- One woman, three autoimmune diseases: CAR-T therapy vanquishes ultra-rare disease trio
- Woman with three deadly diseases has ‘remarkable’ recovery after cell therapy
- Small study hints that revving up immune cells might help fight HIV
- Daily briefing: CAR-T-cell therapy keeps a trio of autoimmune diseases at bay